XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common stock
Public offering
Common stock
At-the-market sales
Common stock
Additional Paid-in Capital.
At-the-market sales
Additional Paid-in Capital.
Accumulated Deficit
At-the-market sales
Total
Balance at Dec. 31, 2022         $ 403,157 $ (408,702)   $ (5,545)
Balance (in shares) at Dec. 31, 2022     859,402          
Increase (decrease) in stockholders' equity                
Share-based compensation - stock options and RSUs         498     498
Issuance of common stock       $ 1,003     $ 1,003  
Issuance of common stock (in shares)   72,699            
Net Income (Loss)           (5,389)   (5,389)
Balance at Mar. 31, 2023         404,658 (414,091)   (9,433)
Balance (in shares) at Mar. 31, 2023     932,101          
Balance at Dec. 31, 2022         403,157 (408,702)   (5,545)
Balance (in shares) at Dec. 31, 2022     859,402          
Increase (decrease) in stockholders' equity                
Net Income (Loss)               (9,197)
Balance at Jun. 30, 2023         405,779 (417,900)   (12,121)
Balance (in shares) at Jun. 30, 2023     1,640,805          
Balance at Mar. 31, 2023         404,658 (414,091)   (9,433)
Balance (in shares) at Mar. 31, 2023     932,101          
Increase (decrease) in stockholders' equity                
Share-based compensation - stock options and RSUs         482     482
Fractional shares retired as a result of reverse split         (13)     (13)
Issuance of common stock       $ 652     $ 652  
Issuance of common stock (in shares) 95,000 105,342            
Exercise of pre-funded warrants (in shares)     508,286          
Vesting of RSUs (in shares)     76          
Net Income (Loss)           (3,809)   (3,809)
Balance at Jun. 30, 2023         405,779 (417,900)   (12,121)
Balance (in shares) at Jun. 30, 2023     1,640,805          
Balance at Dec. 31, 2023     $ 4   406,846 (423,168)   (16,318)
Balance (in shares) at Dec. 31, 2023     2,963,657          
Increase (decrease) in stockholders' equity                
Share-based compensation - stock options and RSUs         333     333
Issuance of common stock in connection with the exercise of common stock warrants, net of expenses     $ 1   4,376     4,377
Issuance of common stock in connection with the exercise of common stock warrants, net of expenses (shares)     3,892,572          
Net Income (Loss)           1,284   1,284
Balance at Mar. 31, 2024     $ 5   411,555 (421,884)   (10,324)
Balance (in shares) at Mar. 31, 2024     6,856,229          
Balance at Dec. 31, 2023     $ 4   406,846 (423,168)   (16,318)
Balance (in shares) at Dec. 31, 2023     2,963,657          
Increase (decrease) in stockholders' equity                
Net Income (Loss)               (10,590)
Balance at Jun. 30, 2024     $ 5   411,839 (433,756)   (21,912)
Balance (in shares) at Jun. 30, 2024     6,904,498          
Balance at Mar. 31, 2024     $ 5   411,555 (421,884)   (10,324)
Balance (in shares) at Mar. 31, 2024     6,856,229          
Increase (decrease) in stockholders' equity                
Share-based compensation - stock options and RSUs         284     284
Vesting of RSUs (in shares)     48,269          
Net Income (Loss)           (11,872)   (11,872)
Balance at Jun. 30, 2024     $ 5   $ 411,839 $ (433,756)   $ (21,912)
Balance (in shares) at Jun. 30, 2024     6,904,498